Recent Articles

October 14, 2016 8:29 am
Ryan Bushey
The site contained about 13 cannabis plants that stretched up to almost 3 feet long when they were placed across a 35-year-old man’s chest diagonally.
October 13, 2016 2:00 pm
Christos Michaelides, Ph.D., Neurology and Opthamology Analyst, GlobalData
Increasing global diagnosed prevalence of MDD and the potential introduction of six late-stage pipeline products will play a role in this growth.
October 13, 2016 8:38 am
Ryan Bushey
The findings suggest that this therapy would be most effective in the early stages of disease.
October 12, 2016 2:00 pm
Another driver of growth is the fact that the UAE generally has a stable political and economic environment, allowing for prosperity.
October 12, 2016 2:12 pm
Stuart A. Scott, PhD and Yao Yang, PhD Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
The enzyme encoded by a single gene, cytochrome P450-2D6 (CYP2D6), is responsible for metabolizing about 25 percent of all commonly used drugs, making it one of the most pharmacologically important genes in the human genome. However, CYP2D6 is not a typical gene.
October 11, 2016 2:51 pm
Ryan Bushey
A batch of mixed data paints a hazy picture for the future of Bristol-Myers Squibb’s immunotherapy Opdivo.
October 10, 2016 1:00 pm
Jennifer Goossens, Associate Analyst, GBI Research
Takeda is expected to take the title of market leader from AbbVie by the end of the forecast period.
October 10, 2016 3:28 pm
Ryan Bushey
Pfizer’s kidney cancer drug received mixed results over the weekend from two studies.
October 7, 2016 2:33 pm
Ryan Bushey
The good news continues rolling in for Johnson & Johnson.
October 6, 2016 1:11 pm
Ryan Bushey
The company’s stock still plummeted more than 40 percent in after-hours trading.
Subscribe to Drug Discovery & Development